Literature DB >> 20630529

Atherosclerosis in Octodon degus (degu) as a model for human disease.

Reynold Homan1, Jeffrey C Hanselman, Sandra Bak-Mueller, Michelle Washburn, Patrick Lester, Heather E Jensen, Stephen L Pinkosky, Christine Castle, Bruce Taylor.   

Abstract

OBJECTIVE: Animal models of atherosclerosis are essential to elucidate disease mechanisms and develop new therapies. Each model features advantages and disadvantages in exemplifying the pathophysiology of human atherosclerosis. Diet-induced development of atherosclerosis in Octodon degus (degu) was examined to demonstrate the potential of the degu as a model of human atherosclerosis.
METHODS: Degus were fed for 16 weeks with either normal chow or chow containing 0.25% cholesterol and 6% palm oil to induce atherosclerosis. The lipid compositions of plasma lipoproteins and aortas were determined. Locations of aortic lesions were mapped by imaging of fluorescently stained aortic lesions. Lesion morphology in the brachiocephalic artery was detected by histological staining.
RESULTS: Total plasma cholesterol in chow-fed degus was distributed approximately 60% in HDL, 30% in LDL and less than 10% in VLDL. Cholesterol-fed degus exhibited 4- to 5-fold increases in total plasma cholesterol, principally in the VLDL and LDL fractions. Cholesteryl ester transfer protein activity of similar magnitude to that in human plasma was detected in chow-fed degu plasma. Cholesterol-fed degus developed cholesteryl ester-rich atherosclerotic lesions throughout the aorta. Histological examination of lesions in the brachiocephalic artery showed well-formed, foam cell-rich lesions populated with inflammatory cells. It is also noteworthy that all the degus in this study exhibited hyperglycemia.
CONCLUSION: These results demonstrate that degus have a human-like lipoprotein metabolism and develop extensive atherosclerosis with cholesterol feeding in the presence of hyperglycemia. These features, combined with the manageable size and handling characteristics, point to the potential of the degu as a useful model for atherosclerosis research. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20630529     DOI: 10.1016/j.atherosclerosis.2010.06.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Long-Term, Fructose-Induced Metabolic Syndrome-Like Condition Is Associated with Higher Metabolism, Reduced Synaptic Plasticity and Cognitive Impairment in Octodon degus.

Authors:  Daniela S Rivera; Carolina B Lindsay; Juan F Codocedo; Laura E Carreño; Daniel Cabrera; Marco A Arrese; Carlos P Vio; Francisco Bozinovic; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2018-04-13       Impact factor: 5.590

2.  Octodon degus (Molina 1782): a model in comparative biology and biomedicine.

Authors:  Alvaro O Ardiles; John Ewer; Monica L Acosta; Alfredo Kirkwood; Agustin D Martinez; Luis A Ebensperger; Francisco Bozinovic; Theresa M Lee; Adrian G Palacios
Journal:  Cold Spring Harb Protoc       Date:  2013-04-01

3.  Genome Sequencing Variations in the Octodon degus, an Unconventional Natural Model of Aging and Alzheimer's Disease.

Authors:  Michael J Hurley; Claudio Urra; B Maximiliano Garduno; Agostino Bruno; Allison Kimbell; Brent Wilkinson; Cristina Marino-Buslje; Marcelo Ezquer; Fernando Ezquer; Pedro F Aburto; Elie Poulin; Rodrigo A Vasquez; Robert Deacon; Ariel Avila; Francisco Altimiras; Peter Whitney Vanderklish; Guido Zampieri; Claudio Angione; Gabriele Constantino; Todd C Holmes; Marcelo P Coba; Xiangmin Xu; Patricia Cogram
Journal:  Front Aging Neurosci       Date:  2022-06-30       Impact factor: 5.702

4.  Octodon degus: a strong attractor for Alzheimer research.

Authors:  Rafael Castro-Fuentes; Rosario Socas-Pérez
Journal:  Basic Clin Neurosci       Date:  2013

Review 5.  On cognitive ecology and the environmental factors that promote Alzheimer disease: lessons from Octodon degus (Rodentia: Octodontidae).

Authors:  Daniela S Rivera; Nibaldo C Inestrosa; Francisco Bozinovic
Journal:  Biol Res       Date:  2016-02-20       Impact factor: 5.612

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.